Skip to content

Exploring the clinical efficacy of the Gu-Ben-Hua-Shi Formula in the treatment of atopic dermatitis and its effect on the skin barrier

Study on the clinical efficacy of Gu-Ben-Hua-Shi Formula in the treatment of atopic dermatitis and its effect on the skin barrier

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000422
Enrollment
Unknown
Registered
2025-02-27
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

Treatment Groups:Gu-Ben-Hua-Shi Formula

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet Williams diagnostic criteria and the TCM meet the diagnostic criteria of spleen deficiency and dampness syndrome; (2) 6-65 years old; (3) gender is not limited; (4) eczema area and severity index method (EASI) > 1; (5) IGA score = 2 ; (6) BSASkin lesion area =2% (2% is equivalent to the area of 2 palms); (7) People with basically normal function of heart liver lungs kidneys and other vital organs; (8) Voluntary participation in this research project good compliance and signing of informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with abnormalities in the blood system liver kidney heart and other systemic examinations; (2) Patients with mental illness malignant tumours diabetes and heart disease pregnant and breastfeeding women; (3) Combined with psoriasis seborrheic dermatitis and other skin diseases affecting the judgement of the skin lesions; (4) Those who have systematically applied glucocorticoids or immunosuppressants (including tretinoin-based preparations) within the last 4 weeks; (5) Those who are known to be allergic to the components of the test drug.

Design outcomes

Primary

MeasureTime frame
EASI;IGA;SCORAD;TEWL;

Secondary

MeasureTime frame
POEM;Pruritus and sleep VAS;DLQI/CDLQI;

Countries

China

Contacts

Public ContactChenDacan

Guangdong Provincial Hospital of Chinese Medicine

cdc@gzucm.edu.cn13602864954

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026